Should You Pick Pfizer Stock At $30?

Pfizer (NYSE: PFE) reported its Q3 results earlier this week, with revenues missing but earnings beating the street estimates, and we believe that PFE stock has ample ...

Related Keywords

,Pfizer ,Health Care ,Trefis High Quality Portfolio ,Peer Comparisons Returnsnov ,Hq Portfolio ,Pfe ,Pfe Stock ,Pfe Revenue ,Pfe Valuation ,